Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Total Net Revenue $ 1,294,209 $ 1,803,424
Total Cost of Sales 588,714 989,375
Gross Profit 705,495 814,049
Operating Expenses:    
Research and development 311,448 369,243
Selling, general and administrative 1,211,103 1,070,610
Depreciation and amortization 13,240 14,795
Total Operating Expenses 1,535,791 1,454,648
Operating Loss (830,296) (640,599)
Other Income (Expenses):    
Gain on debt extinguishment 920,673 0
Interest expense, net (7,873) (8,680)
Total Other Income (Expenses) 912,800 (8,680)
Income (Loss) before Provision for Income Taxes 82,504 (649,279)
Income Taxes Provision (Benefit) (235) 3,222
Net Income (Loss) Attributable to Common Stockholders $ 82,739 $ (652,501)
Net Loss per Common Share:    
Basic - Net Income (Loss) Attributable to Common Stockholders $ .00 $ (0.01)
Diluted - Net Income (Loss) Attributable to Common Stockholders $ .00 $ (0.01)
Weighted Average Common Shares Outstanding used in Computing Basic Net Income/Loss Per Share 136,311,335 135,990,491
Weighted Average Common Shares Outstanding used in Computing Diluted Net Income/Loss Per Share 136,311,335 135,990,491
Product [Member]    
Total Net Revenue $ 1,107,864 $ 1,609,262
Total Cost of Sales 577,814 966,603
Recurring [Member]    
Total Net Revenue 186,345 194,162
Total Cost of Sales $ 10,900 $ 22,772